The Cleo Roberts Center for Clinical Research, Banner-Sun Health Research Institute, Sun City, AZ, USA.
Alzheimers Dement. 2011 Sep;7(5):509-13. doi: 10.1016/j.jalz.2010.12.008. Epub 2011 Jul 1.
Normal pressure hydrocephalus (NPH) is considered to be potentially treatable with the placement of a cerebrospinal fluid (CSF) shunt. However, the procedure has been reported to have variable success, particularly with respect to improving the cognitive impairment in NPH. The presence of neurologic comorbidities, particularly Alzheimer's disease (AD), may contribute to shunt responsiveness. Uncovering the extent to which AD and NPH co-occur has implications for diagnosis and treatment of NPH. Autopsy studies of patients with NPH during their lifetime would elucidate the frequency of such comorbidities.
A search of the Sun Health Research Institute Brain Donation Program database was conducted between January 1, 1997 and April 1, 2009 to identify all cases with neuropathologic evidence of dementia as well as those of clinically diagnosed NPH. We reviewed the medical records and brain findings of each NPH case.
Of the 761 cases autopsied over the study interval, 563 were found to have neuropathologic evidence meeting criteria for a dementing illness. Of 563 cases, AD was found exclusively in 313 (56%), and 94 suffered from secondary diagnosis of dementia. Nine of 761 cases were identified with a clinical diagnosis of NPH, which were among the 563 cases with neuropathology of dementing illness at autopsy, representing 1.6% (9/563) of the cases. On review of brain autopsy reports of these nine patients, eight (89%) were found to have AD and one (11%) had progressive supranuclear palsy. Review of the medical records of the nine NPH cases revealed the following clinical comorbidities: five suffered from AD, one from Parkinson's Disease, one from mild cognitive impairment, and one from seizure disorder.
Given the findings of the present study, we support the AD-NPH theory and posit that AD is a common pathologic comorbidity in the setting of NPH and may preclude cognitive improvement postshunt placement. This may influence the selection of cases for shunting in the future.
常压性脑积水(NPH)被认为可以通过放置脑脊液(CSF)分流器来治疗。然而,该手术的成功率存在差异,特别是在改善 NPH 的认知障碍方面。神经合并症的存在,特别是阿尔茨海默病(AD),可能会影响分流器的反应。揭示 AD 和 NPH 共存的程度对 NPH 的诊断和治疗具有重要意义。对 NPH 患者在有生之年进行尸检研究将阐明此类合并症的发生频率。
1997 年 1 月 1 日至 2009 年 4 月 1 日期间,对 Sun Health 研究机构脑捐赠计划数据库进行了搜索,以确定所有具有神经病理学痴呆证据以及临床诊断为 NPH 的病例。我们回顾了每个 NPH 病例的病历和脑部发现。
在研究期间接受尸检的 761 例病例中,有 563 例被发现具有符合痴呆症标准的神经病理学证据。在 563 例病例中,AD 单独出现在 313 例(56%)中,94 例患有继发性痴呆症。在 761 例病例中,有 9 例被诊断为 NPH,这些病例均在尸检时发现患有神经病理学痴呆症,占尸检时患有神经病理学痴呆症的 563 例的 1.6%(9/563)。对这 9 例患者的脑部尸检报告进行回顾后,发现其中 8 例(89%)患有 AD,1 例(11%)患有进行性核上性麻痹。对这 9 例 NPH 病例的病历进行回顾后发现以下临床合并症:5 例患有 AD,1 例患有帕金森病,1 例患有轻度认知障碍,1 例患有癫痫发作障碍。
鉴于本研究的结果,我们支持 AD-NPH 理论,并认为 AD 是 NPH 中的常见病理性合并症,可能会阻碍分流器放置后的认知改善。这可能会影响未来分流器选择病例的方式。